Creative Biolabs is a leading service provider that focuses on all kinds of lipid-based drug delivery technology. Our strong expertise in delivery system design allows us to help clients tackle challenges and accelerate the design and development of drug delivery.

The role of biological indicators is to introduce highly resistant bacterial spores during the sterilization cycle. If these spores are destroyed, it can be assumed that any contaminating organisms in the load have also been killed, since these organisms are less resistant than the spores and are present in smaller numbers.

Creative Biolabs is one of the well-recognized expert professionals in the field of complement therapeutics and related services. Our technical experts are looking forward to offering high-quality and custom complement inhibitor validation services for our clients.

Immune Checkpoint Assays: <br>Creative Biolabs is a global biotechnology company with years of experience in helping our customers develop their immune checkpoint inhibitors, such as monoclonal antibodies (mAbs), recombinant proteins, peptides, or small molecules, using our innovative immuno-oncology assays.

Creative Biolabs has proudly developed the unique Native™ Antibody Discovery Platform to develop native monoclonal antibodies using antigen-specific B lymphocytes cytometry technology.

At Creative Biolabs, we enhance your research and data relevancy by acquiring and reprogramming induced pluripotent stem cells (iPSC) from a specific patient clinical profile. Our pipeline is designed to meet the clients&#039; project and specific assay requirements for cellular characteristics and functions.

Creative Biolabs focuses on studying the role of γδ T cell in the progression of cancer and discovering new γδ T cell based therapies for cancer. We integrate deep-rooted biological expertise with our comprehensive γδ T profiling and development technologies to rapidly discover and advance a pipeline of γδ T cell based therapy to treat cancer.

TIGIT Immune Checkpoint Molecule for Drug Development: TIGIT (T cell immunoglobulin and ITIM domain), also known as VSig9, Vstm3, or WUCAM, is an inhibitory receptor member of the CD28 family. TIGIT binds to CD155 (PVR or Necl-5) with high affinity and weakly interacts with CD112 (PVRL2, nectin-2). TIGIT also competes with other counterparts, CD266 (DNAM-1) or CD96, to exert its immunosuppressive effects.

As a leading service provider in the field of antibody discovery and immunotherapy development, Creative Biolabs now presents one-stop development services for CAR-T therapy, which has become a more promising approach among cancer therapies. We offer macrophage polarization assay used to improve the antitumor immunity via promoting inflammation during the one-stop service for further downstream research.

Creative Biolabs is determined to provide the best product and service to those at the forefront of their research in live biotherapeutics. Our valuable relationships with our partners and customers drive us to meet their specific requirements with flexible, innovative, and highly customized solutions that transcend current constraints.

With highly specialized equipment and experienced pharmaceutical expert staff, Creative Biolabs is capable to provide a full range of custom lipid-core micelles drug delivery products and services with the highest quality and the most competitive price for global clients.

Neuronal tracers provide incomparable research tools for neuroscience, which enables visualization of neural architecture and identification of neural connections in the brain and nervous system. Neuronal tracers can be considered pathfinders in the nervous system.